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ACCURACY OF FLOW CONVERGENCE M THODS FOR CALCULATING 
MITRAL REGURGITANT FLOW: VALIDATION STUDIES IN AN ANI- 
MAL MODEL. Lilliam Valdes-Cruz. M.D.. FACC, Franc0 
Recusani, H.D., Robin Shandas, B.S., Azucena Murillo, 
M.D., Michael Jones, M.D., FACC, Edward Cape, M.S., 
Valdir Hoises. M.D., Ajit Yoganathan, Ph.D., David J. 
Sahn, M.D., FACC. Univ of Calif, San Diego, CA., Univ 
of Pavia, Italy, and NIH, Bethesda, MD. 
The accelerating flow convergence (FC) in the region 
proximal to regurgitant (REG) orifices has been used to 
calculate constant and pulsatile flows in-vitro. We 
performed open chest epicardial color Doppler (CD) 
scans (Acuson 128, 3.5/5.OHHz,Nyquist limits, 92 and 39 
cm/set) on 10 sheep with chronic (n-5) or acute (n-5) 
mitral REG produced by making a hole in the anterior 
mitral leaflet. Animals were studied under varying 
hemodynamic states (3-5 steady states/animal). Actual 
MR flow (cc/min) was calculated using the effective 
orifice size (measured after sacrifice but during phy- 
siologic distension of excised valves in an in-vitro 
model) X the mean systolic velocity of the MR CW Dop- 
pler curve, cross-checked against implanted MV EM flow 
meters in 2 animals. The FC was measured as maximal 
radius from the first color alias on the LV side of the 
MV to the imaged REG orifice and corrected for phasic 
variation using a mean/max alias distance from MQ mode. 
A hemispherical surface (HS) 2xR2 x NL was used to 
calculate FC MR flow. An excellent correlation of 33 
FC calculated REG flows to actual HR flow ratzs (250 to 
1300 cc/min) (r-0.92, SEE-422 ml/min) was obtained, but 
with a significant systematic overestimation of flow 
rate. FC principles and CD permit calculation of HR 
flows but in a confined LV with a curved MV surface, a 
more complex FC model than the HS we used may be re- 
quired for in-vivo and clinical studies. 
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CALCIUM ANTAGONISTS VARIABLY CHANGE CARDIOVASCULAR MASS 
AND IMPROVE FUNCTION IN RATS 
Edward D. Frohlich, M.D.. F.A.C.C., Osamu Sasaki, M.D., 
Alton Oclisner Medical Foundation, New Orleans, LA 
, Stephen Rockwood,BS, 
VA Medical Center and 
Alpha-adrenergic receptor stimulation results in 
hyperkrophy of neonatal rat cardiac myocytes 
possibly through polyphosphoinositide turnoveb 
(PI) ?? examined 
angiotensi?II (AII) 
the hypothesis that 
through PI, 
which may also operate 
myocytes. 
stimulatk hypertrophy in cardiac 
Neonatal rat cardiac myocytes were 
The effects of calcium entry blockers (CEB) were 
determined in 22 week old Wistar-Kyoto (WKY) and 
spontaneously hypertensive (SHR) rats treated with 
nitrendipine (NTDP, 20 mg/kg), nifedipine (NFDP, 15 
cultured in serum free media supplemented with 
insulin and transferrin. Myocyte cultures were 
treated for various periods of time with AII, 1 
PM norepinephrine (NE) or 10 PM phenylephrine 
(PE), or vehicle. 
measured by 
Total protein accumulation was 
"C-tyrosine incorporation. Results 
are as follows (mean f SEM, n = 4-9): 
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UWrY Protein assays paralleled these findings. 
A related peptide, angiotensin III, had no ef feet 
on protein accumulation. Furthermore, day 11 
mg/kg), or nisoldipine (NSDP, 6 mg/kg) per day for 3 
weeks. Cardiovascular mass and function were assessed by 
measuring left and right ventricular (LV, RV) and aortic 
arch (AA) weights (M), left ventricular performance 
(LV-P) by electromagnetic flowmetry during blood infu 
before and after mean arterial pressure (MAP) rise. a 
aortic distensibility (Ao-D) by pressure-volume curves 
mYocytes did not differ from day 4 myocytes in 
response to treatment. 
adrenergic receptor 
In conclusion, a,- 
stirrlulation results in 
significant increases in protein accumulation in 
rat neonatal cardiac myocyfzes, whereas ~11 has no 
significant effects. 
in vitro. 
(WKY) LVM RVM AAM MAP LV-P Ao-D 
NTDP 0 +7* -12* -12* +* (+)* +* 
NFDP +l +9* -5 -24* +* (+)* +* 
NSDP 
(SHR) $M 
+13* -7 -1o* +* (*) + 
NTDP -5” :!M 
AAM MAP LV-P Ao-D 
-13* -7* +* (f) +* 
NFDP -9* +3 -23* -18* +* (*) +* 
NSDP -7* +13* -15* -14* + (..)” +* 
Values: % change from control. *: p 0.05 vs control; 
-: reduced, f: no change, +: improved before and (after) 
MAF rise. These data show that CEB decreased LVM only 
in SHR and increased RVM within SHR with NSDP and only 
in WKY with the other two agents. In general, they had 
positive functional effects on LV-P and Ao-D. LV-P of 
the reduced SHR-LV after MAP rise was not sustained 
although the unchanged WKY-LV maintained its improved 
performance. 
